Evidence map›Paper›PMID 35900828›Full record

ArticleJMIR formative research2022

Implementing a Health Utility Assessment Platform to Acquire Health Utilities in a Hemodialysis Outpatient Setting: Feasibility Study.

Adeboye A Adejare, Heather J Duncan, R Geoffrey Motz, Silvi Shah, Charuhas V Thakar, Mark H Eckman

Abstract read
In one paragraph

Article in JMIR formative research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Adeboye A AdejareDepartment of Biomedical Informatics, University of Cincinnati, Cincinnati, OH, United States.ORCID https://orcid.org/0000-0003-4378-3626
Heather J DuncanDivision of Nephrology and Hypertension, University of Cincinnati, Cincinnati, OH, United States.ORCID https://orcid.org/0000-0001-9611-4405
R Geoffrey MotzDivision of Nephrology and Hypertension, University of Cincinnati, Cincinnati, OH, United States.ORCID https://orcid.org/0000-0001-8813-0683
Silvi ShahDivision of Nephrology and Hypertension, University of Cincinnati, Cincinnati, OH, United States.ORCID https://orcid.org/0000-0002-9941-9404
Charuhas V ThakarDivision of Nephrology and Hypertension, University of Cincinnati, Cincinnati, OH, United States.ORCID https://orcid.org/0000-0003-3921-5108
Mark H EckmanDivision of General Internal Medicine and the Center for Clinical Effectiveness, University of Cincinnati, Cincinnati, OH, United States.ORCID https://orcid.org/0000-0001-8253-269X

Funding

LCenter for Clinical and Translational Science and TrainingUL1TR001425 · NCATS · UNIVERSITY OF CINCINNATI · PI HEUBI, JAMES E., KISSELA, BRETT M · 2015 to 2024
$37.5M
Improving the Detection of STIs in the Pediatric Emergency Department: A Pragmatic TrialR01HD094213 · NICHD · CHILDREN'S RESEARCH INSTITUTE · PI GOYAL, MONIKA KUMARI, REED, JENNIFER LYNN · 2018 to 2022
$3.3M
Sex Disparities in Cardiovascular Disease and Optimal Coronary Revascularization in Dialysis PatientsK23HL151816 · NHLBI · UNIVERSITY OF CINCINNATI · PI SHAH, SILVI · 2021 to 2025
$1.0M
NCATS NIH HHS UL1 TR001425NHLBI NIH HHS K23 HL151816NICHD NIH HHS R01 HD094213
6 · The paper itself

Abstract

backgroundPatients with end-stage kidney disease (ESKD) wait roughly 4 years for a kidney transplant. A potential way to reduce wait times is using hepatitis C virus (HCV)-viremic kidneys.

objectiveAs preparation for developing a shared decision-making tool to assist patients with ESKD with the decision to accept an HCV-viremic kidney transplant, our initial goal was to assess the feasibility of using The Gambler II, a health utility assessment tool, in an ambulatory dialysis clinic setting. Our secondary goals were to collect health utilities for patients with ESKD and to explore whether the use of race-matched versus race-mismatched exemplars impacted the knowledge gained during the assessment process.

methodsWe used The Gambler II to elicit utilities for the following ESKD-related health states: hemodialysis, kidney transplant with HCV-unexposed kidney, and transplantation with HCV-viremic kidney. We created race exemplar video clips describing these health states and randomly assigned patients into the race-matched or race-mismatched video arms. We obtained utilities for these 3 health states from each patient, and we evaluated knowledge about ESKD and HCV-associated health conditions with pre- and postintervention knowledge assessments.

resultsA total of 63 patients with hemodialysis from 4 outpatient Dialysis Center Inc sites completed the study. Mean adjusted standard gamble utilities for hemodialysis, transplant with HCV-unexposed kidney, and transplantation with HCV-viremic kidney were 82.5, 89, and 75.5, respectively. General group knowledge assessment scores improved by 10 points (P<.05) following utility assessment process. The use of race-matched exemplars had little effect on the results of the knowledge assessment of patients.

conclusionsUsing The Gambler II to collect utilities for patients with ESKD in an ambulatory dialysis clinic setting proved feasible. In addition, educational information about health states provided as part of the utility assessment process tool improved patients' knowledge and understanding about ESKD-related health states and implications of organ transplantation with HCV-viremic kidneys. A wide variation in patient health state utilities reinforces the importance of incorporating patients' preferences into decisions regarding use of HCV-viremic kidneys for transplantation.

Indexed as

end-stage kidney diseasehealth utility assessmenthemodialysishepatitis Cpatient reported outcomes

Identifiers

PMID35900828
PMCPMC9377480

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.